The state of Utah currently has 6 active clinical trials seeking participants for Healthy research studies. These trials are conducted in various cities, including Salt Lake City, Murray, Ogden and West Jordan.
A Study to Evaluate the Safety, Tolerability, Drug Levels, Food, Formulation, and pH Effects on Relative Absorption of BMS-986465 and Its Active Derivative BMS-986464 in Healthy Participants
NCT06144697
Recruiting
The purpose of this study is to evaluate safety, tolerability, drug and food effects on relative bioavailability of BMS-986465 and its active derivative BMS-986464 in healthy participants and healthy participants of Japanese ethnicity.
Gender:
All
Ages:
Between 18 years and 55 years
Trial Updated:
04/22/2024
Locations: Local Institution - 0002, Salt Lake City, Utah
Conditions: Healthy Participants
Register for Updates
A Safety Study of Single and Multiple Doses of AG-181 in Healthy Participants
NCT06286033
Recruiting
The primary purpose of this study is to assess the safety and tolerability of AG-181 in healthy participants after oral administration of single ascending dose (SAD) of AG-181 in Part 1 and multiple ascending dose (MAD) in Part 2 along with the effect of food on the pharmacokinetics (PK) of single oral doses of AG-181 in healthy participants in Part 3.
Gender:
All
Ages:
Between 18 years and 55 years
Trial Updated:
04/15/2024
Locations: ICON 1255 East 3900 South, Salt Lake City, Utah
Conditions: Healthy Volunteers
Register for Updates
Study of an Investigational Pentavalent Meningococcal ABCYW Vaccine in Adults and Adolescents
NCT06128733
Recruiting
The purpose of VAN00010 study is to assess the safety and immunogenicity of the investigational pentavalent meningococcal ABCYW vaccine in adults and adolescents. The study duration will be up to 12 months for all participants.
Gender:
All
Ages:
Between 10 years and 25 years
Trial Updated:
02/20/2024
Locations: Progressive Clinical Research Site Number : 8400028, Bountiful, Utah +2 locations
Conditions: Meningococcal Infection, Healthy Volunteers
Register for Updates
A Study to Evaluate the PK and PD of IM or SQ Injections of Levonorgestrel Butanoate (LB) for Female Contraception
NCT04143659
Recruiting
This is a Phase I multicenter, open-label, dose-ranging, three-dose PK and PD study of injectable LB administered as an IM or SQ injection at 40 mg, and subsequently at 50mg SQ and then 60 mg SQ depending on the preliminary pharmacokinetic and pharmacodynamic results obtained with 40 mg dosing.
Gender:
Female
Ages:
Between 18 years and 40 years
Trial Updated:
08/11/2023
Locations: University of Utah, Salt Lake City, Utah
Conditions: Healthy Women, Female Contraception
Register for Updates
Establish ProLung Test Measurement Collection Protocol for Future Studies.
NCT04134520
Recruiting
The purpose of this Study is to identify and test different data collection methods to determine which approaches improve the ProLung Testing procedure. Once this Study is complete, the Sponsor plans to evaluate these improvements in future follow up Validation studies that will assess device accuracy using the new measurement collection methods.
Gender:
All
Ages:
18 years and above
Trial Updated:
10/21/2022
Locations: Ogden Regional Medical Center, Ogden, Utah +1 locations
Conditions: Cancer , Healthy
Register for Updates
Precision Genomics Medicine Biobank
NCT04187729
Recruiting
The immediate goal of this study is to collect biological samples (i.e., tissue and/or fluid), clinical information, and laboratory data from disease and non-disease subjects seen at Intermountain Healthcare affiliated facilities. The long-term goal is to annotate tissue and/or fluid biomarker data to clinical information and laboratory data for the purpose of improving health care delivery and prognostic potential.
Gender:
All
Ages:
18 years and above
Trial Updated:
04/18/2022
Locations: Intermountain Healthcare, Murray, Utah
Conditions: Any Disease Condition and Reportedly-healthy Subjects
Register for Updates